Supha Pharmachem admitted into insolvency resolution by NCLT after payment defaults. Rajesh Jhunjhunwala appointed as resolution professional....
pharma manufacturing
India's drug regulator enhances oversight of GLP-1 drug distribution to ensure compliance and prevent unauthorized sales. Stricter...
Dr. Reddy's Labs renames a drug to 'Olymra' following court scrutiny. Strategic move to mitigate legal risks...
Warburg Pincus eyes acquisition of Maneesh Pharma unit for $215M. Deal highlights PE interest in India's growing...
India's drug regulator increases scrutiny of GLP-1 weight loss drugs due to unauthorized sales and improper prescriptions....
India's DCGI intensifies crackdown on illegal sales & misleading ads of GLP-1 weight loss drugs. Aiming to...
India's drug regulator increases scrutiny on GLP-1 drugs to prevent misuse and illegal sales, ensuring patient safety...
Indian drugmakers launch affordable generic versions of Ozempic & Wegovy, slashing costs by 70%. Increased access to...
Lilly International President Patrick Johnson sees India as an attractive investment hub, citing faster clinical trial approvals...
Sun Pharma introduces Noveltreat & Sematrinity semaglutide in India, offering affordable alternatives for diabetes & weight management....
